Loading...

Thymosins in Health and Disease II: The Third International Symposium, Volume 1270

ISBN: 978-1-573-31910-2

November 2012

Wiley-Blackwell

252 pages

Description

The second of two volumes, Thymosins in Health and Disease II, continues the exploration of the rapidly expanding area of research in thymosins—a family of proteins, with a broad set of biological properties and great clinical potential.  In this volume, papers detail the important therapeutic implications of two thymosins: Thymosin α1 (Tα1) in relation to immunity, infectious diseases, and cancer, and the clinical and preclinical applications of Thymosin (Tβ4) in cardiovascular regeneration and wound healing. In addition, this volume covers some of the most current topics in thymosin research, including nuclear magnetic resonance imaging structural studies of thymosins, thymosin labeling, antibodies in thymosin research, and new methods for thymosin delivery.

NOTE: Annals volumes are available for sale as individual books or as a journal. For more information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632

ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information on becoming a member.

About the Author

Allan L. Goldstein is professor and Catharine B. & William McCormick Chair of the department of Biochemistry and Molecular Biology at The George Washington University School of Medicine and Health Sciences, where he has served since 1978. He is a world-renowned authority on the thymus gland and the workings of the immune system, and co-discoverer of the thymosins.

Dr. Goldstein is the author of over 400 scientific articles in professional journals, the inventor on more than 15 U.S. Patents, and the editor of several books in the fields of biochemistry, biomedicine, immunology and neuroscience.

He is on the editorial boards of numerous scientific and medical journals and has been a consultant to many research organizations in industry and government; co-founder of The Institute for Advanced Studies in Aging and Geriatric Medicine, a non-profit research and educational institute; a member of the Board of Trustees of the Albert Sabin Vaccine Institute; and serves as the Chairman of the Board of RegeneRx Biopharmaceuticals.

Dr. Goldstein received his B.S. from Wagner College in 1959 and his M.S. and Ph.D. from Rutgers University in 1964. He served as a faculty member of the Albert Einstein College of Medicine from 1964 to 1972, and moved to the University of Texas Medical Branch in Galveston in 1972 as professor and director of the division of Biochemistry.